Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

Kenneth B. Gordon, Richard G. Langley, Craig Leonardi, Darryl Toth, M. Alan Menter, Sewon Kang, Michael Heffernan, Bruce Miller, Regina Hamlin, Liberata Lim, Jianhua Zhong, Rebecca Hoffman, Martin M. Okun

Research output: Contribution to journalArticlepeer-review

423 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study'. Together they form a unique fingerprint.

Medicine & Life Sciences